CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
about
CB2 Cannabinoid Receptor As Potential Target against Alzheimer's DiseaseToward more predictive genetic mouse models of Alzheimer's diseaseThe endocannabinoid system: 'NO' longer anonymous in the control of nitrergic signalling?Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging.Motor, visual and emotional deficits in mice after closed-head mild traumatic brain injury are alleviated by the novel CB2 inverse agonist SMM-189Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortexNeuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.Endocannabinoid system in neurodegenerative disorders.Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway.Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP Transgenic Mice Lacking CB2 Receptors.Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease.
P2860
Q26746050-47EBCFBD-5F33-4F68-A21C-401B3DF8A5D3Q26771883-655B71F7-E573-4662-BC92-FA66CAD915ACQ33712156-1D5D56CD-DE39-419D-A2E5-98315A28C3A3Q33904501-3BA41E1D-500A-48C5-9683-B3F3D7D68987Q35016514-D50EB4EB-5F74-444E-946C-7730F28DADDEQ35044486-D0AA419B-454B-419E-ABFD-C8ED01B4A73AQ38684679-38FBB3C3-A4A0-4526-9B52-441D0EC0E34BQ39368845-7EDBCB6F-F709-4079-A944-E6C9949E5D5FQ48110956-29F34166-2970-48A8-8AAD-F274A9EBE9A2Q48184385-5EC706EB-2BE7-4CC4-B0BA-9E3C005C4B0AQ55078779-4CEDC754-3BEC-42C5-ADD8-9B33A2BBBC12
P2860
CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CB2 receptor deficiency increa ...... model of Alzheimer's disease.
@en
CB2 receptor deficiency increa ...... model of Alzheimer's disease.
@nl
type
label
CB2 receptor deficiency increa ...... model of Alzheimer's disease.
@en
CB2 receptor deficiency increa ...... model of Alzheimer's disease.
@nl
prefLabel
CB2 receptor deficiency increa ...... model of Alzheimer's disease.
@en
CB2 receptor deficiency increa ...... model of Alzheimer's disease.
@nl
P2093
P2860
P1433
P1476
CB2 receptor deficiency increa ...... e model of Alzheimer's disease
@en
P2093
Cristina d'Abramo
Heidy Jimenez
Jeremy Koppel
Mark Stauber
Peter Davies
Rachel Friedman
P2860
P356
10.2119/MOLMED.2013.00140.REVISED
P407
P577
2014-03-14T00:00:00Z
P5875
P6179
1078894762